Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Analyst Ratings

• Total Analysts: 4
• Consensus Rating: Strong Buy
• Price Target: $33.00
• Upside: +291.00%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Julian Harrison BTIG	BTIG	Strong Buy Initiates $40	Strong Buy	Initiates	$40	+373.93%	Dec 19, 2024
Dev Prasad LUCID CAPITAL MARKETS	LUCID CAPITAL MARKETS	Strong Buy Initiates $24	Strong Buy	Initiates	$24	+184.36%	Dec 17, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Oct 24, 2024
Leland Gershell Oppenheimer	Oppenheimer	Hold → Buy Upgrades $35	Hold → Buy	Upgrades	$35	+314.69%	Apr 16, 2024
Leland Gershell Oppenheimer	Oppenheimer	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jun 27, 2023
Gregory Renza RBC Capital	RBC Capital	Buy → Hold Downgrades $2,160 → $180	Buy → Hold	Downgrades	$2,160 → $180	+2,032.70%	Jun 27, 2023
Gregory Renza RBC Capital	RBC Capital	Buy Maintains $4,080 → $2,160	Buy	Maintains	$4,080 → $2,160	+25,492.42%	May 10, 2023
Chris Howerton Jefferies	Jefferies	Hold → Sell Downgrades $720	Hold → Sell	Downgrades	$720	+8,430.81%	Feb 8, 2023
Chris Howerton Jefferies	Jefferies	Strong Buy → Hold Downgrades $14,400 → $2,160	Strong Buy → Hold	Downgrades	$14,400 → $2,160	+25,492.42%	Mar 3, 2022
Gregory Renza RBC Capital	RBC Capital	Buy Maintains $14,400 → $11,520	Buy	Maintains	$14,400 → $11,520	+136,392.89%	Mar 3, 2022
Gregory Renza RBC Capital	RBC Capital	Buy Initiates $17,280	Buy	Initiates	$17,280	+204,639.34%	Sep 24, 2021